These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 35230185)

  • 1. Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis.
    Cadour F; Cautela J; Rapacchi S; Varoquaux A; Habert P; Arnaud F; Jacquier A; Meilhac A; Paganelli F; Lalevée N; Scemama U; Thuny F
    Radiology; 2022 Jun; 303(3):512-521. PubMed ID: 35230185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis.
    Zhao SH; Yun H; Chen CZ; Chen YY; Lin JY; Zeng MS; Liu TS; Pan CZ; Jin H
    Eur Radiol; 2022 Nov; 32(11):7657-7667. PubMed ID: 35567603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac MRI Depicts Immune Checkpoint Inhibitor-induced Myocarditis: A Prospective Study.
    Faron A; Isaak A; Mesropyan N; Reinert M; Schwab K; Sirokay J; Sprinkart AM; Bauernfeind FG; Dabir D; Pieper CC; Heine A; Kuetting D; Attenberger U; Landsberg J; Luetkens JA
    Radiology; 2021 Dec; 301(3):602-609. PubMed ID: 34581628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
    Thavendiranathan P; Zhang L; Zafar A; Drobni ZD; Mahmood SS; Cabral M; Awadalla M; Nohria A; Zlotoff DA; Thuny F; Heinzerling LM; Barac A; Sullivan RJ; Chen CL; Gupta D; Kirchberger MC; Hartmann SE; Weinsaft JW; Gilman HK; Rizvi MA; Kovacina B; Michel C; Sahni G; González-Mansilla A; Calles A; Fernández-Avilés F; Mahmoudi M; Reynolds KL; Ganatra S; Gavira JJ; González NS; García de Yébenes Castro M; Kwong RY; Jerosch-Herold M; Coelho-Filho OR; Afilalo J; Zataraín-Nicolás E; Baksi AJ; Wintersperger BJ; Calvillo-Arguelles O; Ederhy S; Yang EH; Lyon AR; Fradley MG; Neilan TG
    J Am Coll Cardiol; 2021 Mar; 77(12):1503-1516. PubMed ID: 33766256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
    Zhang L; Awadalla M; Mahmood SS; Nohria A; Hassan MZO; Thuny F; Zlotoff DA; Murphy SP; Stone JR; Golden DLA; Alvi RM; Rokicki A; Jones-O'Connor M; Cohen JV; Heinzerling LM; Mulligan C; Armanious M; Barac A; Forrestal BJ; Sullivan RJ; Kwong RY; Yang EH; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Moslehi JJ; Coelho-Filho OR; Ganatra S; Rizvi MA; Sahni G; Tocchetti CG; Mercurio V; Mahmoudi M; Lawrence DP; Reynolds KL; Weinsaft JW; Baksi AJ; Ederhy S; Groarke JD; Lyon AR; Fradley MG; Thavendiranathan P; Neilan TG
    Eur Heart J; 2020 May; 41(18):1733-1743. PubMed ID: 32112560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis.
    Gräni C; Bière L; Eichhorn C; Kaneko K; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1067-1078. PubMed ID: 30756221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
    Higgins AY; Arbune A; Soufer A; Ragheb E; Kwan JM; Lamy J; Henry M; Cuomo JR; Charifa A; Gallegos C; Hull S; Coviello JS; Bader AS; Peters DC; Huber S; Mojibian HR; Sinusas AJ; Kluger H; Baldassarre LA
    PLoS One; 2021; 16(2):e0246764. PubMed ID: 33606757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study.
    Treiber J; Novak D; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Weferling M; von Jeinsen B; Hain A; Rieth AJ; Siemons T; Keller T; Hamm CW; Rolf A
    J Cardiovasc Magn Reson; 2023 Feb; 25(1):8. PubMed ID: 36755275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Characterization by Mapping and Strain Cardiac MRI to Evaluate Myocardial Inflammation in Fulminant Myocarditis.
    Li H; Zhu H; Yang Z; Tang D; Huang L; Xia L
    J Magn Reson Imaging; 2020 Sep; 52(3):930-938. PubMed ID: 32080960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Injury Pattern at MRI in COVID-19 Vaccine-Associated Myocarditis.
    Fronza M; Thavendiranathan P; Chan V; Karur GR; Udell JA; Wald RM; Hong R; Hanneman K
    Radiology; 2022 Sep; 304(3):553-562. PubMed ID: 35166587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.
    Awadalla M; Mahmood SS; Groarke JD; Hassan MZO; Nohria A; Rokicki A; Murphy SP; Mercaldo ND; Zhang L; Zlotoff DA; Reynolds KL; Alvi RM; Banerji D; Liu S; Heinzerling LM; Jones-O'Connor M; Bakar RB; Cohen JV; Kirchberger MC; Sullivan RJ; Gupta D; Mulligan CP; Shah SP; Ganatra S; Rizvi MA; Sahni G; Tocchetti CG; Lawrence DP; Mahmoudi M; Devereux RB; Forrestal BJ; Mandawat A; Lyon AR; Chen CL; Barac A; Hung J; Thavendiranathan P; Picard MH; Thuny F; Ederhy S; Fradley MG; Neilan TG
    J Am Coll Cardiol; 2020 Feb; 75(5):467-478. PubMed ID: 32029128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis.
    Gräni C; Eichhorn C; Bière L; Murthy VL; Agarwal V; Kaneko K; Cuddy S; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
    J Am Coll Cardiol; 2017 Oct; 70(16):1964-1976. PubMed ID: 29025553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying quantitative CMR parameters for detecting myocardial lesion in immune checkpoint inhibitors-associated myocarditis.
    Zhao SH; Yun H; Chen CZ; Chen YY; Lin JY; Zeng MS; Liu TS; Pan CZ; Jin H
    Eur J Radiol; 2022 Nov; 156():110558. PubMed ID: 36265221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subendocardial Involvement as an Underrecognized Cardiac MRI Phenotype in Myocarditis.
    Li JH; Xu XQ; Zhu YJ; Cheng CY; Lu MJ; Wang HY; Wang YN; Jing ZC; Zhao SH
    Radiology; 2022 Jan; 302(1):61-69. PubMed ID: 34636636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Mortality in Patients With Biopsy-Proven Viral Myocarditis: 10-Year Outcome Data.
    Greulich S; Seitz A; Müller KAL; Grün S; Ong P; Ebadi N; Kreisselmeier KP; Seizer P; Bekeredjian R; Zwadlo C; Gräni C; Klingel K; Gawaz M; Sechtem U; Mahrholdt H
    J Am Heart Assoc; 2020 Aug; 9(16):e015351. PubMed ID: 32787653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis.
    Quinaglia T; Gongora C; Awadalla M; Hassan MZO; Zafar A; Drobni ZD; Mahmood SS; Zhang L; Coelho-Filho OR; Suero-Abreu GA; Rizvi MA; Sahni G; Mandawat A; Zatarain-Nicolás E; Mahmoudi M; Sullivan R; Ganatra S; Heinzerling LM; Thuny F; Ederhy S; Gilman HK; Sama S; Nikolaidou S; Mansilla AG; Calles A; Cabral M; Fernández-Avilés F; Gavira JJ; González NS; García de Yébenes Castro M; Barac A; Afilalo J; Zlotoff DA; Zubiri L; Reynolds KL; Devereux R; Hung J; Picard MH; Yang EH; Gupta D; Michel C; Lyon AR; Chen CL; Nohria A; Fradley MG; Thavendiranathan P; Neilan TG
    JACC Cardiovasc Imaging; 2022 Nov; 15(11):1883-1896. PubMed ID: 36357131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.
    Zheng Y; Chen Z; Song W; Xu Y; Zhao Z; Sun Y; Wang Y; Geng X; Zhao J; Zhang X; Xu Y; Chan JSK; Tse G; Li G; Hong L; Liu T
    Cancer Med; 2024 May; 13(10):e7233. PubMed ID: 38752474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac magnetic resonance-based layer-specific strain in immune checkpoint inhibitor-associated myocarditis.
    Li Z; Zhao R; Wang C; Wang Y; Lin J; Zhao S; Chen J; Zhou Y; Liu T; Wang F; Shu X; Zeng M; Cheng L
    ESC Heart Fail; 2024 Apr; 11(2):1061-1075. PubMed ID: 38243390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early evaluation of severe immune checkpoint inhibitor-associated myocarditis: a real-world clinical practice.
    Tang X; Li Y; Huang H; Shi R; Shen LT; Qian WL; Yang ZG
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8345-8357. PubMed ID: 37076643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis: A systematic review and meta-analysis.
    Song W; Zhang N; Lv T; Zhao Y; Li G; Tse G; Liu T
    Cancer Innov; 2024 Jun; 3(3):e109. PubMed ID: 38947756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.